View source for Molnupiravir

==Administration==
*Type: 
*Dosage Forms:
*Routes of Administration:
*Common Trade Names: 

==Adult Dosing==
===[[COVID]]===
* 800 mg q12hr x 5d
* Ages 18 and older only, mild to moderate disease only 
* Within 5 days of symptom onset

==Pediatric Dosing==


==Special Populations==
===[[Drug pregnancy categories|Pregnancy Rating]]===
*Avoid in pregnant or young patients given concern for mutagenicity 

===Lactation risk===
*

===Renal Dosing===
*Adult:
*Pediatric:

===Hepatic Dosing===
*Adult:
*Pediatric:

==Contraindications==
*Allergy to class/drug

==Adverse Reactions==
===Serious===


===Common===


==Pharmacology==
*Half-life: 
*Metabolism: 
*Excretion: 

==Mechanism of Action==


==Comments==
* Phase 3 trial showed 30% reduction in risk of hospitalization or death 

==See Also==


==References==
<references/>

[[Category:Pharmacology]]